I’m involved in other events on Sunday too. https://www.weforum.org/events/annual-meeting-of-the-global-future-councils-2017 #gfc17
Read more
Space tourism will take-off in 2018. As the race between spaceflight companies Virgin Galactic and SpaceX heats up, those who can afford it will be able to travel to low Earth orbit and possibly even around the moon.
Click here to subscribe to The Economist on YouTube: http://econ.st/2he5ZAb
In late 2018, tourists will be heading into space and there is a race on to get them there. Virgin Galactic will at last take paying customers beyond the stratosphere. But their efforts might be eclipsed by SpaceX, a company planning to send two tourists around the Moon. Taking them farther into space than any human since 1972.
There is a new breed of would-be astronauts for whom the sky is no limit. But it is not in everyone’s reach. Multi-millionaire entrepreneur, Per Wimmer will be one of the first tourists to go into space with private company, Virgin Galactic.
By sending quantum information several kilometers, the researchers took a big step toward the future of information security.
A team of Chinese researchers say they have completed the first long-distance quantum secure direct communication, a critical step toward sending messages that are truly safe from eavesdropping.
The information traveled 2.7 kilometers along a quantum channel, the team said in a paper that was peer-reviewed by China’s Science Bulletin journal and placed online Oct. 22.
Read more
Dear Future (Trailer)
Posted in alien life, nuclear energy, robotics/AI
WATCH THE FIRST EPISODE NOW: http://bit.ly/2yuwDPF
Check out CNET’s channel: http://bit.ly/2gpeXdr
Dear Future is Motherboard and CNET’s new documentary series built on the premise that technology and science are still capable of wowing us. Fusion energy, DIY off-grid energy systems, decentralized mesh networks, the search for life on other planets, and humanoid robots aren’t far-off science fiction, they’re breakthroughs that are happening right now.
Follow MOTHERBOARD
Future U.S. military tanks may look and perform nothing like they do today.
In fact, they may not even have windows and instead seal military personnel inside a closed cockpit to better protect them against threats.
But how could they see the battlefield around them without windows? To see outside, Soldiers could use a new technology made by Honeywell that lets them “see” with virtual reality and augmented reality.
Read more
Today’s Sputnik moment is China’s rapid growth as an economic and technological superpower. In 2017 alone, China has outpaced the United States in renewable energy efforts and has become the standard-bearer in combating climate change and advocacy for globalization. Similarly, China is rapidly moving towards taking the lead in technology from the United States and is looking at quantum computing and artificial intelligence as areas for growth to do so.
The Verge recently published an article citing Alphabet chief executive officer Eric Schmidt’s perspective that the United States is falling behind when it comes to research and development in artificial intelligence, particularly compared to the rapid pace of innovation that China has set in the field. Schmidt, who is also the chair of the Defense Innovation Advisory Board, gave those remarks as part of a discussion at The Artificial Intelligence and Global Security Summit held by The Center for a New American Security (CNAS), a nonprofit think tank dedicated to research and analysis on how the United States can make informed policy-making decisions on national security and defense.
Read more
Our CEO, Liz Parrish was invited at this event for a keynote interview with Charles Goddard, the editorial director for The Economist Asia Pacific Intelligence Unit. They discussed the complexity of regulations, the extraordinarily long time it takes for drug development from bench to bedside, the current funding environment surrounding biotech, and the pace of medical innovations. During the keynote, Liz emphasized that BioViva’s main aim is to make advanced gene and cell therapies available to all patients in need. To further this cause BioViva supports innovative and adaptive clinical trials, new models for preclinical testing, and accelerating the time to develop advanced gene and cell therapy. Finally, Liz highlighted the importance of testing gene and cell therapy in humans as quickly as possible, because animal models are not accurate.
Read more